Intra-Cellular Therapies Inc (ITCI)
72.36
+0.32
(+0.44%)
USD |
NASDAQ |
Apr 19, 16:00
72.36
0.00 (0.00%)
After-Hours: 20:00
Intra-Cellular Therapies Price: 72.36 for April 19, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 18, 2024 | 74.40 | 75.08 | 71.20 | 72.04 | 4.290M |
Apr 17, 2024 | 79.00 | 83.25 | 76.50 | 76.69 | 2.862M |
Apr 16, 2024 | 75.29 | 84.89 | 75.00 | 79.84 | 7.381M |
Apr 15, 2024 | 65.71 | 66.05 | 64.16 | 64.76 | 503322.0 |
Apr 12, 2024 | 68.04 | 68.67 | 64.84 | 65.88 | 586929.0 |
Apr 11, 2024 | 67.89 | 68.68 | 66.53 | 67.97 | 431105.0 |
Apr 10, 2024 | 67.12 | 68.12 | 66.53 | 67.28 | 541589.0 |
Apr 09, 2024 | 68.07 | 69.02 | 67.90 | 68.62 | 493243.0 |
Apr 08, 2024 | 68.74 | 68.90 | 67.32 | 67.70 | 376861.0 |
Apr 05, 2024 | 67.29 | 69.50 | 67.02 | 68.44 | 702125.0 |
Apr 04, 2024 | 68.49 | 69.33 | 66.61 | 67.21 | 661496.0 |
Apr 03, 2024 | 66.28 | 68.73 | 65.99 | 67.32 | 586293.0 |
Apr 02, 2024 | 66.94 | 67.55 | 65.93 | 66.67 | 502775.0 |
Apr 01, 2024 | 69.20 | 69.36 | 67.73 | 68.27 | 367886.0 |
Mar 28, 2024 | 69.78 | 70.00 | 68.14 | 69.20 | 878657.0 |
Mar 27, 2024 | 67.94 | 69.75 | 67.50 | 69.72 | 428676.0 |
Mar 26, 2024 | 68.88 | 69.27 | 67.13 | 67.33 | 303687.0 |
Mar 25, 2024 | 69.59 | 70.07 | 67.82 | 67.97 | 639309.0 |
Mar 22, 2024 | 68.74 | 69.90 | 68.74 | 69.02 | 821338.0 |
Mar 21, 2024 | 67.78 | 69.27 | 67.38 | 68.38 | 631587.0 |
Mar 20, 2024 | 65.50 | 67.41 | 64.95 | 67.21 | 978929.0 |
Mar 19, 2024 | 63.91 | 66.67 | 63.87 | 65.45 | 519085.0 |
Mar 18, 2024 | 64.97 | 65.98 | 64.75 | 65.37 | 488612.0 |
Mar 15, 2024 | 64.46 | 65.09 | 63.92 | 64.78 | 1.071M |
Mar 14, 2024 | 64.96 | 65.10 | 63.30 | 64.57 | 610667.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
7.26
Minimum
Oct 01 2019
79.84
Maximum
Apr 16 2024
39.52
Average
40.38
Median
Jan 11 2022
Price Benchmarks
Insmed Inc | 24.36 |
Fate Therapeutics Inc | 4.80 |
ADMA Biologics Inc | 6.27 |
Rhythm Pharmaceuticals Inc | 37.98 |
Amylyx Pharmaceuticals Inc | 1.88 |
Price Related Metrics
PS Ratio | 15.01 |
Price to Book Value | 11.84 |
Earnings Yield | -2.02% |
Market Cap | 7.005B |